Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diagnosis of Myeloproliferative Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00022048
What this trial is testing

Bevacizumab in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Stanford University
Not applicableEnded earlyNCT02455024
What this trial is testing

An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG®

Who this might be right for
Myeloid Leukemia, Chronic-Phase, Accelerated-Phase, Blast-Phase, Ph+ALL
Ariad Pharmaceuticals 3
Testing effectiveness (Phase 2)UnknownNCT01227135
What this trial is testing

Imatinib Mesylate With or Without Hydroxychloroquine in Treating Patients With Chronic Myeloid Leukemia

Who this might be right for
Leukemia
Lynn McMahon 66
Early research (Phase 1)Study completedNCT00077558
What this trial is testing

3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Post-approval studies (Phase 4)Ended earlyNCT05853458
What this trial is testing

Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors

Who this might be right for
Polycythemia Vera
Novartis Pharmaceuticals 76
Testing effectiveness (Phase 2)Study completedNCT01819558
What this trial is testing

Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid Hemopathy

Who this might be right for
Acute Myeloid LeukemiaChronic Myeloid LeukemiaMyelodysplastic Syndrome
Institut Paoli-Calmettes 2
Testing effectiveness (Phase 2)Study completedNCT00053989
What this trial is testing

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Roswell Park Cancer Institute 41
Not applicableStudy completedNCT06945146
What this trial is testing

Genomics Study in CML Patients With Ponatinib Treatment

Who this might be right for
Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Dong-Wook Kim 65
Not applicableStudy completedNCT06692803
What this trial is testing

Real-World Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia in Earlier Lines of Therapy

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 2,043
Testing effectiveness (Phase 2)Study completedNCT01273766
What this trial is testing

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+133 more
Wake Forest University Health Sciences 16
Testing effectiveness (Phase 2)Study completedNCT03625388
What this trial is testing

Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
Hikma Pharmaceuticals LLC 56
Testing effectiveness (Phase 2)Study completedNCT02896842
What this trial is testing

A Prospective Randomized Phase II Study Evaluating the Monitoring of Imatinib Mesylate Plasmatic Through Level in Patients Newly Diagnosed With CP-CML

Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Versailles Hospital 139
Testing effectiveness (Phase 2)Study completedNCT00823524
What this trial is testing

Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more
Asan Medical Center 47
Large-scale testing (Phase 3)Ended earlyNCT02115386
What this trial is testing

Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib

Who this might be right for
Philadelphia Positive (Ph+) Chronic Myeloid Leukemia
Novartis Pharmaceuticals 7
Early research (Phase 1)Study completedNCT00295841
What this trial is testing

Cytarabine and Clofarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Wake Forest University Health Sciences 53
Testing effectiveness (Phase 2)Looking for participantsNCT04935684
What this trial is testing

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

Who this might be right for
Acute Leukemia in RemissionMyelodysplastic SyndromesMyeloproliferative Syndrome+4 more
University Hospital, Clermont-Ferrand 150
Not applicableStudy completedNCT03726944
What this trial is testing

The Feasibility of Delivering Consumer-based Meditation Applications to Myeloproliferative Neoplasm Patients

Who this might be right for
Myeloproliferative Neoplasm
Arizona State University 128
Large-scale testing (Phase 3)Study completedNCT00003687
What this trial is testing

Treatment for Chronic Pain in Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
NCIC Clinical Trials Group 87
Not applicableUnknownNCT01562847
What this trial is testing

Prospective Investigation of Dynamics of ABL Mutations in Imatinib Failed CML Patients Treated With Nilotinib

Who this might be right for
Chronic Myeloid Leukemia
Seoul St. Mary's Hospital 125
Early research (Phase 1)Looking for participantsNCT05636514
What this trial is testing

Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic LeukemiaAcute Myeloid Leukemia
Clinical Hub for Interventional Research (CHOIR) 12
Next Page